Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan
· Delayed Price · Currency is JPY 5,314.00
-45.00 (-0.84%)
May 9, 2025, 3:30 PM JST
Kobayashi Pharmaceutical Revenue
In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B JPY, down -4.53%. Kobayashi Pharmaceutical had revenue of 51.14B in the quarter ending December 31, 2024, a decrease of -5.89%.
Revenue
165.60B
Revenue Growth
-4.53%
P/S Ratio
2.39
Revenue / Employee
45.81M
Employees
3,615
Market Cap
395.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Japan Tobacco | 3,236.41B |
| Seven & i Holdings | 10.34T |
| Asahi Group Holdings | 2,939.42B |
| Ajinomoto Co. | 1,522.62B |
| Kao Corporation | 1,628.45B |
| Pan Pacific International Holdings | 2,176.10B |
| Unicharm | 988.98B |
| Kirin Holdings Company | 2,338.39B |